Yao Lee

BIOVIA, Inc. develops and commercializes scientific informatics software products and services for industries and organizations that rely on scientific innovation. Its enterprise platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. The company by incorporating its capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, it enables scientific innovators to access, organize, analyze and share data in various ways. BIOVIA was founded in 1993 and is headquartered in San Diego, CA.

IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT.

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland.

Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan.

Regeneus Ltd. is regenerative medicine company, which develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Paddington, Australia.